James B. Tananbaum

Jim Tananbaum, MD ’89, MBA ’91, is the founder and chief executive officer of Foresite Capital, a U.S.-focused healthcare investment firm established in 2011 that has approximately $3 billion in assets under management. During the last three decades, Jim has been a thought partner for some of the most impactful and fastest growth companies of their generation, including 10x Genomics, Amerigroup, and Jazz Pharmaceuticals. A four-time Midas List honoree, he currently serves as a member of the Yale University Council and the advisory committee of Yale School of Engineering & Applied Science.

As an undergraduate, Jim attended Yale, where he graduated with a BS and BSEE in applied math and electrical engineering/computer science. He then earned an MD from Harvard, graduating from the Harvard-MIT Program in Health Sciences and Technology (HST). He also earned an MBA from Harvard while playing rugby.